Gilles Freyer Selected Research

Gilles Freyer Research Topics

Disease

33	Neoplasms (Cancer) 01/2022 - 01/2003
14	Breast Neoplasms (Breast Cancer) 09/2021 - 01/2002
13	Ovarian Neoplasms (Ovarian Cancer) 06/2021 - 05/2011
6	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 05/2002
5	Disease Progression 01/2022 - 03/2012
5	Carcinoma (Carcinomatosis) 01/2022 - 05/2012
5	Prostatic Neoplasms (Prostate Cancer) 11/2021 - 04/2003
3	Ovarian Epithelial Carcinoma 01/2018 - 01/2015
3	Neoplasm Metastasis (Metastasis) 01/2018 - 04/2003
3	Graft vs Host Disease (Graft-Versus-Host Disease) 03/2011 - 01/2007
2	Neutropenia 01/2022 - 01/2013
2	Circulating Neoplastic Cells 11/2021 - 01/2021
2	Gestational Trophoblastic Disease (Trophoblastic Neoplasms, Gestational) 01/2020 - 01/2017
2	Lung Neoplasms (Lung Cancer) 10/2017 - 06/2013
2	Febrile Neutropenia 06/2016 - 10/2015
2	Melanoma (Melanoma, Malignant) 11/2014 - 06/2013
2	Endometrial Neoplasms (Endometrial Cancer) 12/2013 - 04/2003
2	Pathologic Complete Response 05/2012 - 04/2002
1	Cicatrix (Scar) 11/2021
1	COVID-19 10/2021
1	Trophoblastic Neoplasms (Trophoblastic Tumor) 01/2020
1	Transient Ischemic Attack 01/2019
1	Thrombotic Microangiopathies 01/2018
1	Constipation 11/2016
1	Hypoalbuminemia 10/2016
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 06/2016
1	Renal Cell Carcinoma (Grawitz Tumor) 05/2016
1	Lymphoma (Lymphomas) 11/2015

Drug/Important Bio-Agent (IBA)

8	PlatinumIBA 12/2021 - 01/2015
6	Pharmaceutical PreparationsIBA 06/2017 - 02/2003
5	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2022 - 01/2013
5	Hormones (Hormone)IBA 09/2021 - 04/2003
5	Docetaxel (Taxotere)FDA Link 04/2016 - 01/2002
4	Biomarkers (Surrogate Marker)IBA 11/2021 - 06/2013
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022 - 11/2021
3	Indicators and Reagents (Reagents)IBA 12/2021 - 06/2020
3	Bevacizumab (Avastin)FDA Link 11/2021 - 01/2011
3	Biological ProductsIBA 11/2021 - 11/2014
3	Carboplatin (JM8)FDA LinkGeneric 06/2021 - 12/2015
3	Paclitaxel (Taxol)FDA LinkGeneric 06/2021 - 01/2011
3	Trastuzumab (Herceptin)FDA Link 01/2019 - 01/2011
3	ErbB Receptors (EGF Receptor)IBA 01/2019 - 01/2011
3	Capecitabine (Xeloda)FDA Link 01/2018 - 01/2011
3	Everolimus FDA Link 01/2015 - 08/2012
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2014 - 05/2002
3	Fluorouracil (Carac)FDA LinkGeneric 01/2011 - 05/2002
2	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 02/2003
2	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 01/2022 - 01/2013
2	Androgen Receptors (Androgen Receptor)IBA 11/2021 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 11/2021 - 10/2017
2	Tumor Biomarkers (Tumor Markers)IBA 11/2021 - 12/2013
2	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 01/2020 - 01/2020
2	Etoposide (VP 16)FDA LinkGeneric 11/2015 - 11/2008
2	Sorafenib (BAY 43-9006)FDA Link 01/2015 - 02/2014
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 03/2011 - 12/2010
2	Leucovorin (Folinic Acid)FDA Link 01/2011 - 05/2002
1	eribulin FDA Link 01/2022
1	Messenger RNA (mRNA)IBA 11/2021
1	LigandsIBA 11/2021
1	Oxygen (Dioxygen)IBA 10/2021
1	enzalutamideIBA 01/2021
1	abirateroneIBA 01/2021
1	Methotrexate (Mexate)FDA LinkGeneric 01/2020
1	avelumabIBA 01/2020
1	Adenosine Diphosphate (ADP)IBA 12/2019
1	Adenosine Diphosphate Ribose (ADP-Ribose)IBA 12/2019
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 12/2019
1	niraparibIBA 12/2019
1	TransferasesIBA 01/2019
1	AntigensIBA 01/2019
1	trebananibIBA 01/2019
1	liposomal doxorubicin (Doxil)FDA Link 01/2019
1	thiaclopridIBA 01/2019
1	palbociclibIBA 01/2018
1	Cell-Free Nucleic AcidsIBA 10/2017
1	B7-H1 AntigenIBA 01/2017
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 10/2016
1	Prostate-Specific Antigen (Semenogelase)IBA 06/2016
1	Epirubicin (Ellence)FDA LinkGeneric 04/2016
1	BI 6727IBA 03/2016
1	Carmustine (FIVB)FDA Link 11/2015
1	Cytarabine (Cytosar-U)FDA LinkGeneric 11/2015
1	Melphalan (Alkeran)FDA LinkGeneric 11/2015

Therapy/Procedure

31	Drug Therapy (Chemotherapy) 01/2022 - 01/2003
19	Therapeutics 11/2021 - 01/2003
3	Radiotherapy 01/2018 - 01/2003
2	Castration 11/2021 - 01/2021
2	Neoadjuvant Therapy 11/2021 - 01/2020
2	Medication Errors (Medication Error) 01/2013 - 11/2011
2	Drug Tapering 01/2013 - 02/2012
1	Length of Stay 10/2021
1	Adjuvant Chemotherapy 09/2021
1	Molecular Targeted Therapy 10/2019
1	Hyperthermic Intraperitoneal Chemotherapy 01/2018
1	Curettage 01/2018
1	Cytoreduction Surgical Procedures 01/2018
1	Injections 06/2017
1	Activities of Daily Living (ADL) 10/2016
1	Aftercare (After-Treatment) 03/2016
1	BEAM regimen 11/2015